Quick Takeaways
- James B. Weissman has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,430.
- Recent insider filing activity is available below.
Insider Trading & Ownership of James B. Weissman
- Location
- San Diego, CA
- Summary
- The estimated net worth of James B. Weissman is at least $4,430 dollars as of 26 Jul 2024. James B. Weissman is the Director of Telesis Bio Inc. and owns shares of Telesis Bio Inc. stock worth about $4.4K.
- Signature
- /s/ Rob Cutler, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow James B. Weissman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Telesis Bio Inc. ($4,430).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of James B. Weissman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TBIO | Telesis Bio Inc. | Director | $4,430 | 24 Jul 2024 | ||
| DRNA | Dicerna Pharmaceuticals Inc | Chief Operating Officer & EVP | 28 Dec 2021 |
Insider Transactions Reported by James B. Weissman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.